BAM
DXCM icon

Belpointe Asset Management’s DexCom DXCM Stock Holding History

Belpointe Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,844
Closed -$255K – 1098
2025
Q4 		$255K Buy
+3,844
New +$249K 0.01% 871
2024
Q2 		– Sell
-5,371
Closed -$745K – 872
2024
Q1 		$745K Buy
+5,371
New +$675K 0.06% 343
2023
Q3 		– Sell
-1,744
Closed -$224K – 672
2023
Q2 		$224K Sell
1,744
-1,549
-47% -$187K 0.02% 542
2023
Q1 		$383K Buy
3,293
+467
+17% +$52.3K 0.02% 654
2022
Q4 		$320K Buy
2,826
+77
+3% +$8.45K 0.02% 707
2022
Q3 		$222K Sell
2,749
-151
-5% -$12.8K 0.02% 788
2022
Q2 		$216K Buy
2,900
+80
+3% +$7.3K 0.01% 796
2022
Q1 		$361K Buy
2,820
+1,516
+116% +$166K 0.02% 650
2021
Q4 		$176K Sell
1,304
-44
-3% -$6.32K 0.01% 946
2021
Q3 		$184K Sell
1,348
-508
-27% -$64.1K 0.01% 886
2021
Q2 		$198K Buy
+1,856
New +$178K 0.01% 840
2020
Q3 		– Sell
-4,000
Closed -$406K – 791
2020
Q2 		$406K Buy
+4,000
New +$358K 0.05% 342

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Belpointe Asset Management's DXCM Position: Q1 2026 in Review

Belpointe Asset Management sold out of DexCom (DXCM) in Q1 2026, closing a stake of 3,844 shares — an estimated $255K sold.

Belpointe Asset Management first reported a position in DXCM in Q2 2020 and held it in 12 quarters. The position peaked at $745K in Q1 2024. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Belpointe Asset Management reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Belpointe Asset Management sold 3,844 DexCom shares in Q1 2026, an estimated $255K.
  • Belpointe Asset Management first reported a position in DexCom in Q2 2020 and held it in 12 quarters.
  • Belpointe Asset Management's DexCom position peaked at $745K in Q1 2024.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Belpointe Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.